Segall Bryant & Hamill LLC Invests $1.28 Million in Masimo Co. (MASI) Stock

Segall Bryant & Hamill LLC acquired a new stake in Masimo Co. (NASDAQ:MASI) in the 2nd quarter, HoldingsChannel.com reports. The firm acquired 13,107 shares of the medical equipment provider’s stock, valued at approximately $1,280,000.

A number of other large investors have also recently bought and sold shares of MASI. Point72 Asset Management L.P. increased its stake in Masimo by 102.0% in the 1st quarter. Point72 Asset Management L.P. now owns 1,381,945 shares of the medical equipment provider’s stock valued at $121,542,000 after buying an additional 697,920 shares during the last quarter. Champlain Investment Partners LLC boosted its stake in Masimo by 248.8% during the first quarter. Champlain Investment Partners LLC now owns 692,780 shares of the medical equipment provider’s stock worth $60,930,000 after acquiring an additional 494,180 shares in the last quarter. Citigroup Inc. boosted its stake in Masimo by 2,334.5% during the first quarter. Citigroup Inc. now owns 464,312 shares of the medical equipment provider’s stock worth $40,836,000 after acquiring an additional 445,240 shares in the last quarter. Rockefeller Capital Management L.P. bought a new stake in Masimo during the first quarter worth about $29,980,000. Finally, First Quadrant L P CA bought a new stake in Masimo during the second quarter worth about $16,537,000. Hedge funds and other institutional investors own 83.88% of the company’s stock.

Shares of Masimo stock opened at $117.30 on Monday. The stock has a market capitalization of $6.07 billion, a price-to-earnings ratio of 47.88, a PEG ratio of 2.74 and a beta of 0.89. Masimo Co. has a 52-week low of $80.69 and a 52-week high of $118.09.

Masimo (NASDAQ:MASI) last issued its earnings results on Wednesday, August 1st. The medical equipment provider reported $0.73 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.02. The business had revenue of $211.62 million during the quarter, compared to analysts’ expectations of $207.85 million. Masimo had a net margin of 15.30% and a return on equity of 21.49%. The business’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.83 earnings per share. sell-side analysts predict that Masimo Co. will post 2.9 EPS for the current fiscal year.

MASI has been the topic of several research reports. ValuEngine lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Thursday, June 7th. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research note on Monday, May 7th. BidaskClub raised shares of Masimo from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, May 8th. Piper Jaffray Companies boosted their price objective on shares of Masimo to $94.00 and gave the stock a “neutral” rating in a research note on Wednesday, May 2nd. Finally, Stifel Nicolaus boosted their price objective on shares of Masimo from $108.00 to $112.00 and gave the stock a “buy” rating in a research note on Thursday, August 2nd. Two equities research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Masimo presently has an average rating of “Buy” and a consensus target price of $102.60.

In other Masimo news, CAO Ramshorst David J. Van sold 3,000 shares of Masimo stock in a transaction dated Wednesday, May 30th. The shares were sold at an average price of $100.00, for a total value of $300,000.00. Following the completion of the transaction, the chief accounting officer now directly owns 4,000 shares of the company’s stock, valued at $400,000. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Steven Barker sold 10,000 shares of Masimo stock in a transaction dated Wednesday, May 30th. The stock was sold at an average price of $100.00, for a total transaction of $1,000,000.00. Following the completion of the transaction, the director now directly owns 73,249 shares of the company’s stock, valued at $7,324,900. The disclosure for this sale can be found here. Insiders sold 118,347 shares of company stock valued at $12,746,589 over the last ninety days. Corporate insiders own 12.60% of the company’s stock.

Masimo Profile

Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through-motion and low-perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry.

Read More: Do closed-end mutual funds pay dividends?

Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Co. (NASDAQ:MASI).

Institutional Ownership by Quarter for Masimo (NASDAQ:MASI)

Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply